Feedback
ZYDUSLIFE 
Reputation: 642,681 • Jul 27, 2023 7:03 PM
Zydus Lifesciences gains 5% on USFDA nod for cancer drug
The plerixafor injection, used by patients with certain types of cancer to prepare them for a stem cell transplant, will be manufactured at the group’s facility in Ahmedabad
Moneycontrol
1 Vote
Comment
Share
NSE:ZYDUSLIFE price when posted: 655.15
View Votes